quality of care

Interview

Making Decisions About New Cancer Treatments With Limited Evidence

11/15/2016

Jim C Hu, MD, MPH

An interview with Jim C Hu, MD, MPH, urologic oncologist and director of the LeFrak Center for Robotic Surgery at NewYork-Presbyterian and Weill Cornell Medicine, New York, NY.  Prostate cancer...

An...

11/15/2016

Journal of Clinical Pathways

Research in Review

Review Examines Prognostic Value of Tumor-Infiltrating Lymphocytes in Early Breast Cancer

11/15/2016

JCP Editors

Tumor-infiltrating lymphocytes (TILs) have been described in various tumors, including breast cancer. In early breast cancer, the presence of TILs is associated with better outcomes and response to therapy. A review...

...

11/15/2016

Journal of Clinical Pathways

Research in Review

Analysis Finds Tocilizumab Superior to Conventional DMARDs in RA

11/15/2016

JCP Editors

A comparative effectiveness analysis of biologics for rheumatoid arthritis (RA) showed that tocilizumab monotherapy and tocilizumab plus methotrexate were superior to conventional disease-modifying antirheumatic...

A...

11/15/2016

Journal of Clinical Pathways

Research in Review

Chest Pain Clinical Pathway in Pediatric ED Can Influence Resource Use

11/15/2016

JCP Editors

Because most young children are not able to accurately describe or localize their pain, ruling out cardiac disease in children can be challenging, leading to increased health care utilization for chest pain...

...

11/15/2016

Journal of Clinical Pathways

Research in Review

Pediatric Stroke Pathway Improves Time to Definitive Diagnosis

11/15/2016

JCP Editors

A pediatric stroke clinical pathway significantly improved time to definitive diagnosis while also streamlining the care provided to children presenting to the pediatric emergency department (ED) with focal...

A...

11/15/2016

Journal of Clinical Pathways

Research in Review

Feedback System Improves Physician Adherence to Oncology Clinical Pathways

11/15/2016

JCP Editors

While clinical pathways have emerged as a way of reducing care variability and standardizing best practice, some institutions that implement these tools still face difficulties with physician buy-in and adherence to...

While...

11/15/2016

Journal of Clinical Pathways

Research in Review

Tailored Dose-Dense Chemotherapy Does Not Improve RFS in Early Breast Cancer

11/10/2016

JCP Editors

The use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy does not result in significant improvement in high-risk early breast cancer recurrence-free survival (RFS), according to a...

The...

11/10/2016

Journal of Clinical Pathways

Research in Review

PD-1 Inhibitors Best Targeted Therapy for Advanced Melanoma

11/08/2016

JCP Editors

A combination of immunotherapy treatments improves survival and lowers the risk of life-threatening events for patients with late-stage melanoma compared with targeted therapy, according to a new JAMA Oncology...

A...

11/08/2016

Journal of Clinical Pathways

Research in Review

Recurrence Score Assay Helping to Guide Breast Cancer Decision Making

10/26/2016

JCP Editors

Use of the 21-gene recurrence score (RS) assay is helping clinicians and patients decide which treatments are best for them, according to a large-scale survey of more than 3000 women treated for breast...

Use of...

10/26/2016

Journal of Clinical Pathways

Department

Biomarker Tied to Immunotherapy Response in Melanoma

09/30/2016

JCP Editors

Researchers at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, have identified a potential biomarker in patients with stage IV melanoma being treated with the immunotherapy...

...

09/30/2016

Journal of Clinical Pathways